National hospital Organization Mito Medical Center

Higashiibaraki, Ibaraki 311-3193

0 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, Cancer, Heart Failure, Prevention of Stroke or Systemic Embolism

Studies at this site

• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction — Completed